Seeking AlphaWed, 13 May 2026 17:00:49 GMTReplimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1REPL+29.58%
BenzingaMon, 13 Apr 2026 17:44:33 GMTFDA Rejection Sparks Questions On Replimune Drug Approval PathREPL+29.58%
Zacks Investment ResearchMon, 13 Apr 2026 16:35:18 GMTReplimune Gets Second FDA CRL for Melanoma Drug BLA, Stock CrashesREPL+29.58%
CNBC TelevisionMon, 13 Apr 2026 15:46:13 GMTReplimune co-founder calls FDA rejection of melanoma drug ‘unfair'REPL+29.58%
Zacks Investment ResearchTue, 03 Mar 2026 15:56:09 GMTDoes Replimune Group (REPL) Have the Potential to Rally 79.61% as Wall Street Analysts Expect?REPL+29.58%
